Sarah Louise Stenton-Seeger (@SL_Stenton) header
Sarah Louise Stenton-Seeger (@SL_Stenton) profile picture

Deciphering the genetic cause of rare diseases | Variant Assessment Scientist @ Ambry Genetics

San Francisco, CA
Joined February 2022
Sarah Louise Stenton-Seeger retweeted
📢 Check out the preprint of the GREGoR Research Consortium Marker paper! arxiv.org/abs/2412.14338 See our collaborative approach to accelerating diagnoses and diversifying genomics through data generation and sharing, innovative computational methods, and deep phenotyping.🧬
10
1
26
2,766
Sarah Louise Stenton-Seeger retweeted
Forthcoming guidance will recommend labs report VUS subclasses. We share experience of 4 labs including rates of reclassification of VUS subclasses. By highlighting VUS-high and downplaying VUS-low, this will be game-changing for dx genetic testing. buff.ly/3Cpx5RL
32
96
6,803
Sarah Louise Stenton-Seeger retweeted
Excited to report our study in @NEJM on the discovery of deletions in a long noncoding RNA gene 🧬 (𝘊𝘏𝘈𝘚𝘌𝘙𝘙) as the cause of a newly defined human neurodevelopmental disorder 🧠. 🧵1/10 nejm.org/doi/full/10.1056/NE…
12
88
7
380
50,825
Sarah Louise Stenton-Seeger retweeted
See our paper in GIM here. If you publish on variants, PLEASE use variantvalidator.org/, or even better, just submit them to ClinVar before article submission (you can request a 6 month embargo), to both validate your variant naming AND make them findable by all!
GIM's Senior Technical Editor Peter Freeman collaborated with other experts on "Standardizing variant naming in literature with VariantValidator to increase diagnostic rates", now available in Nature Genetics bit.ly/3BF83On
1
36
1
130
16,275
Sarah Louise Stenton-Seeger retweeted
Excited to share our @Nature paper introducing constraint metrics for #mtDNA! Constraint models are powerful tools that were missing for mtDNA—until now. By applying our model to #gnomAD, we reveal which sites in mtDNA are most crucial for health & disease nature.com/articles/s41586-0…
12
57
1
209
24,415
Sarah Louise Stenton-Seeger retweeted
Analysis of R-loop forming regions identifies RNU2-2P and RNU5B-1 as neurodevelopmental disorder genes medrxiv.org/cgi/content/shor… #medRxiv
1
8
2,067
Sarah Louise Stenton-Seeger retweeted
Use of PP3/BP4 evidence from calibrated computational prediction tools has little impact on the number of variants classified as Pathogenic or Likely Pathogenic #ACMG/AMP #variantclassification #computational predictors bit.ly/3ZtV0cn
13
1
23
3,722
Sarah Louise Stenton-Seeger retweeted
Another splicesomal RNA implicated in recurrent mutations leading to neurodevelopmental disorders, and yet again based on the whole genome sequencing of patients @GenomicsEngland who consented for responsible on going research to help understand their (or their child's) disease
Mutations in the U2 snRNA gene RNU2-2P cause a severe neurodevelopmental disorder with prominent epilepsy #RareDisease #Genetics #morbidgene medrxiv.org/content/10.1101/…
2
6
22
6,012
Sarah Louise Stenton-Seeger retweeted
I wrote a blog post to break down the science behind RNU4-2 in a way that families could understand: rarediseasegenomics.org/blog… Key lesson: truly lay writing is incredibly important, but also super hard (this took me a while!) If you have any RNU4-2 families, please do share!
4
20
1
81
5,721
Sarah Louise Stenton-Seeger retweeted
I very much enjoyed writing this @NatureNV piece on the RNU4-2 story. Please read on if you want to learn more about how a non-coding variant was discovered to be one of the most frequent causes for developmental diseases. (thx M. Rissom for sketch) nature.com/articles/d41586-0…
1
8
2
30
7,689
Sarah Louise Stenton-Seeger retweeted
"feeling that like we’ve been on this deserted island for eight years and now all of a sudden, you’re sort of like looking around through the branches of the trees. It’s like, wait a minute, there are other people on this island" ❤️
New episode! Our guests discuss the impact of the research discovery that linked an RNU4-2 gene variant to neurodevelopmental disorders. Naimah Callachand is joined by Lindsay Pearse, Sarah Wynn and Emma Baple 🎙️ Listen via this link: genomicsengland.co.uk/podcas… @Unique_charity
1
9
33
2,877
Sarah Louise Stenton-Seeger retweeted
A lovely piece on the impact of our work by @iansample @guardian including a lovely quote from an RNU4-2 mum: "This where the data meets real life. We like to refer to RNU4-2 as “renew”, as our family is being renewed by this new information and hope for the future.” ❤️
Scientists uncover genetic disorder that may affect thousands around world dlvr.it/T9SXM3
10
1
69
7,799
Sarah Louise Stenton-Seeger retweeted
We explored why pathogenic variants are present in the gnomAD database for early-onset, severe, dominant conditions. Explanations identified for most but some likely due to incomplete penetrance though more study needed. 1/3
2
38
1
115
23,424
Sarah Louise Stenton-Seeger retweeted
Exploring penetrance of clinically relevant variants in over 800,000 humans from the Genome Aggregation Database biorxiv.org/cgi/content/shor… #biorxiv_genomic
6
14
2,807
Sarah Louise Stenton-Seeger retweeted
Happy to share our latest work where we evaluate the effectiveness of missense variant effect predictors in classifying the disease relevance of variants. This work was done as part of the CAGI6 Annotate-All-Missense challenge. 🧵 biorxiv.org/content/10.1101/…
1
8
1
14
2,883
Sarah Louise Stenton-Seeger retweeted
Excited to share our work on the diagnostic power of genome sequencing when directly assessing cases with exome data - 8% additional yield - if we analyze genomes as more than an exome. Thanks @HereAtMonica @RamiAbouJamra @HeidiRehm and Broad CMG @GREGoR_research collaborators!
Original Article: Genome Sequencing for Diagnosing Rare Diseases nej.md/3yP6iwE #Genetics
2
20
87
9,168